Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats
Introduction: Cisplatin (CP) is an anti-cancer drug with the most common side effects of nephrotoxicity. Losartan, an angiotensin II type 1 receptor (AT1R) antagonist and angiotensin 1-7 (Ang1-7) protects the kidney against CP administration in males Moreover, the activity of the renin angiotensin s...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Society of Diabetic Nephropathy Prevention
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea0645b4b1904d5093f609349facec66 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ea0645b4b1904d5093f609349facec66 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ea0645b4b1904d5093f609349facec662021-11-17T08:15:00ZAngiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats2345-420210.34172/npj.2022.10https://doaj.org/article/ea0645b4b1904d5093f609349facec662022-01-01T00:00:00Zhttps://jnephropharmacology.com/PDF/npj-10380https://doaj.org/toc/2345-4202Introduction: Cisplatin (CP) is an anti-cancer drug with the most common side effects of nephrotoxicity. Losartan, an angiotensin II type 1 receptor (AT1R) antagonist and angiotensin 1-7 (Ang1-7) protects the kidney against CP administration in males Moreover, the activity of the renin angiotensin system (RAS) and the incidence of CP induced nephrotoxicity are gender related. Objectives: The role of Ang1-7 and losartan against CP induced nephrotoxicity in female rats was examined. Methods: Thirty-two female Wistar rats in five experimental groups were treated with vehicle, single dose of CP (7.5 mg/kg), CP+losartan (10 ), CP+Ang1-7 (30 μg/kg/d) or CP+Ang1-7+A779 (Mas receptor antagonist, 100 μg/kg/d). The biochemical and histology measurements were conducted one week later. Results: The levels of serum creatinine (Cr) and blood urea nitrogen (BUN) in serum increased insignificantly by CP alone administration. However co-treatment of CP with losartan, Ang1-7, or Ang1-7 plus A779 showed an increase of the serum levels of BUN and Cr, and kidney tissue damage score (KTDS) (P < 0.05) when compared with control groups. Conclusion: The AT1R and Mas receptor (MasR) antagonists and Ang1-7 administration promote the CP induced damage of kidney in female rats, and special attention is needed during CP therapy in hypertensive patients who are treating with anti-hypertensive drug of losartan.Sayyedehnikta KasaeiZahra PezeshkiFarzaneh KarimiZahra LakSamira ChoopaniArdeshir TalebiMehdi NematbakhshSociety of Diabetic Nephropathy Prevention articleangiotensin 1-7losartancisplatinTherapeutics. PharmacologyRM1-950Diseases of the genitourinary system. UrologyRC870-923ENJournal of Nephropharmacology, Vol 11, Iss 1, Pp e10-e10 (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
angiotensin 1-7 losartan cisplatin Therapeutics. Pharmacology RM1-950 Diseases of the genitourinary system. Urology RC870-923 |
spellingShingle |
angiotensin 1-7 losartan cisplatin Therapeutics. Pharmacology RM1-950 Diseases of the genitourinary system. Urology RC870-923 Sayyedehnikta Kasaei Zahra Pezeshki Farzaneh Karimi Zahra Lak Samira Choopani Ardeshir Talebi Mehdi Nematbakhsh Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
description |
Introduction: Cisplatin (CP) is an anti-cancer drug with the most common side effects of nephrotoxicity. Losartan, an angiotensin II type 1 receptor (AT1R) antagonist and angiotensin 1-7 (Ang1-7) protects the kidney against CP administration in males Moreover, the activity of the renin angiotensin system (RAS) and the incidence of CP induced nephrotoxicity are gender related. Objectives: The role of Ang1-7 and losartan against CP induced nephrotoxicity in female rats was examined. Methods: Thirty-two female Wistar rats in five experimental groups were treated with vehicle, single dose of CP (7.5 mg/kg), CP+losartan (10 ), CP+Ang1-7 (30 μg/kg/d) or CP+Ang1-7+A779 (Mas receptor antagonist, 100 μg/kg/d). The biochemical and histology measurements were conducted one week later. Results: The levels of serum creatinine (Cr) and blood urea nitrogen (BUN) in serum increased insignificantly by CP alone administration. However co-treatment of CP with losartan, Ang1-7, or Ang1-7 plus A779 showed an increase of the serum levels of BUN and Cr, and kidney tissue damage score (KTDS) (P < 0.05) when compared with control groups. Conclusion: The AT1R and Mas receptor (MasR) antagonists and Ang1-7 administration promote the CP induced damage of kidney in female rats, and special attention is needed during CP therapy in hypertensive patients who are treating with anti-hypertensive drug of losartan. |
format |
article |
author |
Sayyedehnikta Kasaei Zahra Pezeshki Farzaneh Karimi Zahra Lak Samira Choopani Ardeshir Talebi Mehdi Nematbakhsh |
author_facet |
Sayyedehnikta Kasaei Zahra Pezeshki Farzaneh Karimi Zahra Lak Samira Choopani Ardeshir Talebi Mehdi Nematbakhsh |
author_sort |
Sayyedehnikta Kasaei |
title |
Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
title_short |
Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
title_full |
Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
title_fullStr |
Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
title_full_unstemmed |
Angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
title_sort |
angiotensin 1-7 and losartan worsen the cisplatin induced nephrotoxicity in female rats |
publisher |
Society of Diabetic Nephropathy Prevention |
publishDate |
2022 |
url |
https://doaj.org/article/ea0645b4b1904d5093f609349facec66 |
work_keys_str_mv |
AT sayyedehniktakasaei angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats AT zahrapezeshki angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats AT farzanehkarimi angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats AT zahralak angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats AT samirachoopani angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats AT ardeshirtalebi angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats AT mehdinematbakhsh angiotensin17andlosartanworsenthecisplatininducednephrotoxicityinfemalerats |
_version_ |
1718425837397606400 |